Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 30, 2015 3:36 AM ET

Healthcare Equipment and Supplies

Company Overview of Provista Diagnostics, Inc.

Company Overview

Provista Diagnostics, Inc. is a molecular diagnostics company that focuses on developing and commercializing blood-based diagnostic, prognostic, and monitoring tests to address the unmet needs in women's cancers. The company develops a pipeline of blood-based molecular diagnostic tests to address the unmet needs in breast, ovarian, endometrial, and human papillomavirus (HPV) associated cancers. Its products include Videssa Breast, a biomarker panel along with patient data and statistical modeling to improve standard of care in women with suspicious breast lesions; Videssa Ovarian, a blood-based biomarker assay to aid in the earlier diagnosis of ovarian cancer and monitor for recurrence; Vide...

160 Varick Street

Suite 1101A

New York, NY 10013

United States

Founded in 2007





Key Executives for Provista Diagnostics, Inc.

Chief Executive Officer and President
Age: 43
Chief Financial Officer
Age: 61
Chief Operating Officer
Chief Commercial Officer
Chief Strategic Officer
Compensation as of Fiscal Year 2015.

Provista Diagnostics, Inc. Key Developments

Provista Diagnostics, Inc. Presents at Canaccord Genuity 2015 Medical Technology & Diagnostics Forum, Nov-19-2015 01:20 PM

Provista Diagnostics, Inc. Presents at Canaccord Genuity 2015 Medical Technology & Diagnostics Forum, Nov-19-2015 01:20 PM. Venue: Westin Grand Central, New York, New York, United States. Speakers: David E. Reese, Chief Executive Officer and President.

Provista Diagnostics, Inc. Presents at 14th Annual BIO Investor Forum, Oct-21-2015 08:00 AM

Provista Diagnostics, Inc. Presents at 14th Annual BIO Investor Forum, Oct-21-2015 08:00 AM. Venue: Parc 55 Hotel, San Francisco, California, United States.

Provista Diagnostics, Inc. Completes Enrollment of the 2nd Cohort of its 002 Prospective, Multi-Center, Randomized Trial Utilizing the Provista Biomarker Assay to Aid in the Detection of Breast Cancer

Provista Diagnostics, Inc. announced that they completed enrollment of the 2nd cohort of a prospective study of their protein-based biomarker blood test to aid in detection of breast cancer. Provista's 2nd cohort of its 002 study enrolled a total of 509 women that will be monitored for 6 and 12 months for clinical outcomes. Together, cohorts 1 and 2 of Provista's 002 study has recruited a total of 1,020 patients. The study is a prospective, multi-center, randomized trial that seeks to validate Provista's blood-based biomarker panel assay in conjunction with imaging to differentiate benign breast lesions from invasive cancers. This multi-center trial is a follow-up to Provista's 001 trial that recruited 351 women under the age of 50 with suspicious lesions thus, bringing Provista's collective prospective clinical trial enrollment to 1,371 patients to date. To evaluate whether Provista's blood test could aid in the detection of breast cancer, patients were prospectively enrolled in a randomized trial at 12 breast cancer centers across the United States. A small quantity of blood was drawn from patients to analyze several protein biomarkers and their expression patterns were evaluated by a proprietary algorithm to yield a unique protein signature. The goal of the study is to determine whether a collection of biomarkers identified by Provista's test can differentiate malignant from benign tumors.

Similar Private Companies By Industry

Company Name Region
Freudenberg Medical, LLC United States
Medical Equipment Company, Inc. United States
Elm Tree Medical Inc. United States
DiaSorin Inc. United States

Recent Private Companies Transactions

Private Placement
July 23, 2015
Private Placement
February 17, 2015

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Provista Diagnostics, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at